Andrew B. Gainey

642 total citations
7 papers, 142 citations indexed

About

Andrew B. Gainey is a scholar working on Pharmacology, Molecular Medicine and Ecology. According to data from OpenAlex, Andrew B. Gainey has authored 7 papers receiving a total of 142 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 3 papers in Molecular Medicine and 2 papers in Ecology. Recurrent topics in Andrew B. Gainey's work include Antibiotic Resistance in Bacteria (3 papers), Bacteriophages and microbial interactions (2 papers) and Drug-Induced Adverse Reactions (2 papers). Andrew B. Gainey is often cited by papers focused on Antibiotic Resistance in Bacteria (3 papers), Bacteriophages and microbial interactions (2 papers) and Drug-Induced Adverse Reactions (2 papers). Andrew B. Gainey collaborates with scholars based in United States. Andrew B. Gainey's co-authors include Anna‐Kathryn Burch, Robert Daniels, Michael Brownstein, Joseph Fackler, Biswajit Biswas, David E. Brown, Francisco Malagón, Bri’Anna Horne, P. Brandon Bookstaver and Melissa B. Jones and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and The Pediatric Infectious Disease Journal.

In The Last Decade

Andrew B. Gainey

7 papers receiving 136 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew B. Gainey United States 4 56 53 44 38 27 7 142
Anna‐Kathryn Burch United States 4 53 0.9× 53 1.0× 29 0.7× 34 0.9× 27 1.0× 5 124
Michelle Prickett United States 7 92 1.6× 10 0.2× 37 0.8× 37 1.0× 76 2.8× 17 189
Xinqian Ma China 8 53 0.9× 9 0.2× 30 0.7× 45 1.2× 17 0.6× 19 167
Mélanie Fromentin France 6 16 0.3× 41 0.8× 4 0.1× 36 0.9× 30 1.1× 9 139
Lorella Pelagalli Italy 7 56 1.0× 9 0.2× 9 0.2× 28 0.7× 12 0.4× 10 149
Maria T. Nelson United States 7 26 0.5× 28 0.5× 9 0.2× 85 2.2× 104 3.9× 10 275
Ayşe Büyükçam Türkiye 7 24 0.4× 6 0.1× 9 0.2× 33 0.9× 15 0.6× 23 179
Manuela Iten Switzerland 4 25 0.4× 108 2.0× 3 0.1× 39 1.0× 8 0.3× 16 154
Giulia Errico Italy 6 84 1.5× 11 0.2× 27 0.6× 41 1.1× 5 0.2× 15 155
Léna Mazza Switzerland 5 73 1.3× 9 0.2× 33 0.8× 24 0.6× 10 0.4× 7 260

Countries citing papers authored by Andrew B. Gainey

Since Specialization
Citations

This map shows the geographic impact of Andrew B. Gainey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew B. Gainey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew B. Gainey more than expected).

Fields of papers citing papers by Andrew B. Gainey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew B. Gainey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew B. Gainey. The network helps show where Andrew B. Gainey may publish in the future.

Co-authorship network of co-authors of Andrew B. Gainey

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew B. Gainey. A scholar is included among the top collaborators of Andrew B. Gainey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew B. Gainey. Andrew B. Gainey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Hsu, Alice J., Kathleen Chiotos, Laura Bio, et al.. (2025). Suggested Dosing of Select Beta-lactam Agents for the Treatment of Antimicrobial-Resistant Gram-Negative Infections in Children. Journal of the Pediatric Infectious Diseases Society. 14(2). 3 indexed citations
2.
Daniels, Robert, et al.. (2023). Providing value to patients and providers via a pediatric statewide antibiogram in South Carolina. SHILAP Revista de lepidopterología. 3(1). e78–e78. 2 indexed citations
3.
Gainey, Andrew B., Robert Daniels, Anna‐Kathryn Burch, et al.. (2022). Recurrent ESBL Escherichia coli Urosepsis in a Pediatric Renal Transplant Patient Treated With Antibiotics and Bacteriophage Therapy. The Pediatric Infectious Disease Journal. 42(1). 43–46. 13 indexed citations
4.
Gainey, Andrew B., et al.. (2021). Evaluation of Time to Resolution of Medical Necrotizing Enterocolitis Using Severity-Guided Management in a Neonatal Intensive Care Unit. The Journal of Pediatric Pharmacology and Therapeutics. 26(2). 179–186. 3 indexed citations
5.
Gainey, Andrew B., Anna‐Kathryn Burch, Michael Brownstein, et al.. (2020). Combining bacteriophages with cefiderocol and meropenem/vaborbactam to treat a pan‐drug resistant Achromobacter species infection in a pediatric cystic fibrosis patient. Pediatric Pulmonology. 55(11). 2990–2994. 74 indexed citations
6.
Bartelt, Luther A., Anne M. Lachiewicz, Kathleen Tompkins, et al.. (2020). Cefiderocol for the Treatment of Adult and Pediatric Patients With Cystic Fibrosis and Achromobacter xylosoxidans Infections. Clinical Infectious Diseases. 73(7). e1754–e1757. 34 indexed citations
7.
Bookstaver, P. Brandon, et al.. (2012). Fatal Clindamycin‐Induced D rug R ash with E osinophilia and S ystemic S ymptoms (DRESS) Syndrome. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 32(12). e387–92. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna‐Kathryn Burch Breakdown of academic impact, for papers by Michelle Prickett Breakdown of academic impact, for papers by Xinqian Ma Breakdown of academic impact, for papers by Mélanie Fromentin Breakdown of academic impact, for papers by Lorella Pelagalli Breakdown of academic impact, for papers by Maria T. Nelson Breakdown of academic impact, for papers by Ayşe Büyükçam Breakdown of academic impact, for papers by Manuela Iten Breakdown of academic impact, for papers by Giulia Errico Breakdown of academic impact, for papers by Léna Mazza
Rankless by CCL
2026